Drugs for Children

The “Therapeutic Orphan” status of children is gradually improving, but our efforts to eliminate off‐label/off‐evidence use must be sustained for safer and more effective pediatric drug therapy. This is even more important in resource‐scarce settings, because of the increasing child population in those regions. The juncture of pediatric pharmacology and global child health represents an emerging field of clinical pharmacology illuminating a crucial societal need on a global scale.

[1]  SM MacLeod Improving Medicine Use for Children: A Global Imperative , 2017, Clinical pharmacology and therapeutics.

[2]  M. Rieder,et al.  Adverse Drug Reactions in Children: The Double‐Edged Sword of Therapeutics , 2017, Clinical pharmacology and therapeutics.

[3]  K. Hoppu Essential Medicines for Children , 2017, Clinical pharmacology and therapeutics.

[4]  S. Ito,et al.  Children: Are We Doing Enough? , 2015, Clinical pharmacology and therapeutics.

[5]  K. Neville,et al.  Off-Label Use of Drugs in Children , 2014, Pediatrics.

[6]  R. Stafford,et al.  Off-label prescribing among office-based physicians. , 2006, Archives of internal medicine.

[7]  Christopher Stoakes,et al.  The global imperative , 1999 .